Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration
Cells · 2025
DOI: 10.3390/cells14241938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Magdalena Patrycy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical and Environmental Microbiology, Military Institute of Hygiene and Epidemiology, 01-163 Warsaw, Poland. Hauptthemen laut MEDLINE: Fas Ligand Protein, fas Receptor, Herpesvirus 1, Human, Herpes Simplex. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland, NAWA Bekker scholarship, Wenner-Gren Foundation scholarship.
Abstract (Originalsprache)
Many studies have shown an association between herpes simplex virus type 1 (HSV-1) infection and the development of neurodegeneration processes later in life, such as Alzheimer’s disease. The Fas/FasL death pathway plays an important role in the complex regulation of the local inflammatory response and mounting of the specific antiviral response in HSV-1 infection. Here, we applied a mouse model of latent HSV-1 neuroinfection to Fas- and FasL-deficient mice (lpr and gld) to explore whether the lack of functional Fas/FasL pathway protects from inflammation-related neurodegeneration. The latently infected Fas- and FasL-deficient mice (lpr and gld) were not protected from virus replication despite the accumulation of virus-specific cytotoxic T cells. However, the lack of Fas/FasL pathway decreased neuroinflammation- and neurodegeneration-related markers, including cognitive impairment, amyloid-β protein, and tau hyperphosphorylation. The use of a glucocorticoid, dexamethasone, to decrease neuroinflammation in wild-type mice did not protect from cognitive impairment, despite the improved antiviral response. Our data indicate that excessive neuroinflammation via the Fas/FasL pathway during HSV-1 infection is associated with neurodegeneration. Furthermore, the administration of immunomodulatory agents to ameliorate the outcome of HSV-1 latent infection should be restricted to the peak of neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical and Environmental Microbiology, Military Institute of Hygiene and Epidemiology, 01-163 Warsaw, Poland.
- PORT Polish Center for Technology Development, 54-066 Wroclaw, Poland.
- Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
- Department of Pharmaceutical Chemistry and Biomaterials, Faculty of Pharmacy, Warsaw Medical University, 02-097 Warsaw, Poland.
ORCID-Profile: Aleksandra Osińska, Małgorzata Antos-Bielska, Marcin Chodkowski, Małgorzata Krzyżowska
Förderung
- National Science Centre Poland
- NAWA Bekker scholarship
- Wenner-Gren Foundation scholarship
- NAWA Bekker
- Wenner-Gren Foundation
Zitieren
APA
Patrycy, M., Kauc, A., Janicka, M., Osińska, A., Kowalczyk, A., Skulska, K., Antos-Bielska, M., Chodkowski, M., Eriksson, K., & Krzyżowska, M. (2025). Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration. Cells. https://doi.org/10.3390/cells14241938
Vancouver
Patrycy M, Kauc A, Janicka M, Osińska A, Kowalczyk A, Skulska K, et al. Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration. Cells. 2025. doi:10.3390/cells14241938
BibTeX
@article{Patrycy2025,
author = {Patrycy, Magdalena and Kauc, Agnieszka and Janicka, Martyna and Osińska, Aleksandra and Kowalczyk, Andrzej and Skulska, Katarzyna and Antos-Bielska, Małgorzata and Chodkowski, Marcin and Eriksson, Kristina and Krzyżowska, Małgorzata},
title = {Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14241938}
}
EUVIMED